You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced multiple sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in New York (Active tDCS, Sham () stimulation)

Recruiting
  • Multiple Sclerosis
  • Active tDCS
  • Sham (placebo) stimulation
  • New York, New York
    New York University School of Medicine
Dec 28, 2022

Upper Extremity Function in Multiple Sclerosis Advanced

Active, not recruiting
  • Multiple Sclerosis
  • +7 more
  • Tampa, Florida
    Carol and Frank Morsani Center for Advanced Healthcare
Nov 2, 2022

Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)

Recruiting
  • Advanced Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Cladribine (MAVENCLAD®)
  • Placebo
  • Belfast, United Kingdom
  • +18 more
Jun 9, 2022

Multiple Sclerosis, Inflammatory Demyelinating Disease Trial in Rochester (C-11 ER176 Radiotracer, C11 Pittsburgh Compound B,

Not yet recruiting
  • Multiple Sclerosis
  • Inflammatory Demyelinating Disease
  • C-11 ER176 Radiotracer
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic Minnesota
Mar 28, 2023

Multiple Sclerosis, Dry Eye Syndromes, Diabetic Retinopathy Trial in Miami (Ocufolin)

Recruiting
  • Multiple Sclerosis
  • +5 more
  • Ocufolin
  • Miami, Florida
    Bascom Palmer Eye Institute
Oct 18, 2022

Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)

Recruiting
  • Multiple Sclerosis (MS)
  • Relapsing Remitting Multiple Sclerosis
  • Cullman, Alabama
  • +14 more
Dec 13, 2022

Multiple Sclerosis Trial in Aurora (Low-Load Exercise with Blood Flow Restriction, Low-Load Exercise Control Group)

Not yet recruiting
  • Multiple Sclerosis
  • Low-Load Exercise with Blood Flow Restriction
  • Low-Load Exercise Control Group
  • Aurora, Colorado
    Rocky Mountain Regional VA Medical Center, Aurora, CO
Aug 12, 2022

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

Active, not recruiting
  • Primary Progressive Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • ATA188
  • Placebo
  • La Jolla, California
  • +33 more
Jul 21, 2022

Multiple Sclerosis, Quality of Life, Patient Empowerment Trial in Spain (Multiple Sclerosis Expert Patient Program of Catalonia)

Recruiting
  • Multiple Sclerosis
  • +5 more
  • Multiple Sclerosis Expert Patient Program of Catalonia
  • Barcelona, Spain
  • +4 more
Dec 10, 2021

Suboptimally Controlled Participants Previously Taking Oral or

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Cullman, Alabama
  • +66 more
Nov 29, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Aggressive Therapy or Traditional Therapy
  • Birmingham, Alabama
  • +51 more
Jan 23, 2023

Multiple Sclerosis Trial in Istanbul (Inspiratory Muscle Training, Balance Exercises)

Recruiting
  • Multiple Sclerosis
  • Inspiratory Muscle Training
  • Balance Exercises
  • Istanbul, Şişli, Turkey
    Prof. Dr. Cemil Taşçıoğlu Şehir Hastanesi
Oct 4, 2023

Multiple Sclerosis Trial in Worldwide (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Fort Collins, Colorado
  • +27 more
Aug 24, 2022

Multiple Sclerosis Trial in Canada, Puerto Rico, United States (RPC-1063)

Recruiting
  • Multiple Sclerosis
  • Birmingham, Alabama
  • +110 more
Jan 3, 2023

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Mitochondrial Dysfunction in Primary Progressive Multiple

Recruiting
  • Multiple Sclerosis
    • Milan, MI, Italy
    • +1 more
    Aug 29, 2023

    Relapsing Multiple Sclerosis, Multiple Sclerosis Trial (Placebo, Pirtobrutinib)

    Not yet recruiting
    • Relapsing Multiple Sclerosis
    • Multiple Sclerosis
    • (no location specified)
    Oct 24, 2023

    Sleep Disorders and Quality of Life in Multiple Sclerosis

    Not yet recruiting
    • Sleep Disorder
      • (no location specified)
      Aug 24, 2023

      Orofacial Pain in Multiple Sclerosis

      Recruiting
      • Multiple Sclerosis
      • Diagnosis of pain
      • Varaždin, Croatia
        Varazdin General Hospital
      Sep 5, 2023

      Multiple Sclerosis Trial in Hamburg (levidex, Control, treatment as usual (TAU))

      Not yet recruiting
      • Multiple Sclerosis
      • levidex
      • +2 more
      • Hamburg, Germany
        GAIA AG
      Oct 19, 2023

      Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive Trial in Cleveland (Cionic

      Recruiting
      • Multiple Sclerosis
      • +2 more
      • Cionic Neural Sleeve NS-100
      • Actigraph accelerometer
      • Cleveland, Ohio
        Cleveland State University
      Jul 25, 2023

      Magnetic Resonance Imaging to Evaluate Activity of Multiple

      Recruiting
      • Multiple Sclerosis
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 30, 2023

        Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

        Not yet recruiting
        • Multiple Sclerosis
        • +2 more
        • KYV-101 anti-CD19 CAR-T cell therapy
        • Standard lymphodepletion regimen
        • Palo Alto, California
          Stanford Multiple Sclerosis Center
        Nov 13, 2023

        Multiple Sclerosis, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

        Not yet recruiting
        • Multiple Sclerosis
        • +2 more
        • Patient Participation Form
        • (no location specified)
        Feb 25, 2023

        Ofatumumab in Portuguese Multiple Sclerosis Patients

        Not yet recruiting
        • Relapsing Multiple Sclerosis
        • Ofatumumab
        • (no location specified)
        Mar 30, 2023